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SPAKa b s t r a c t
The neuron-specific K-Cl cotransporter KCC2 maintains the low intracellular chloride concentration
required for the fast hyperpolarizing responses of the inhibitory neurotransmitters c-aminobutyric acid
(GABA) and glycine. The two KCC2 isoforms, KCC2a and KCC2b differ by their N-termini as a result of
alternative promoter usage. Whereas the role of KCC2b in mediating the chloride transport is unequivo-
cal, the physiological role of KCC2a in neurons has remained obscure. We show that KCC2a isoform can
decrease the intracellular chloride concentration in cultured neurons and attenuate calcium responses
evoked by application of the GABAA receptor agonist muscimol. While the biotinylation assay detected
both KCC2 isoforms at the cell surface of cultured neurons, KCC2a was not detected at the plasma mem-
brane in immunostainings, suggesting that the N-terminal KCC2a epitope is masked. Confirming this
hypothesis, KCC2a surface expression was detected by the C-terminal KCC2 pan antibody but not by
the N-terminal KCC2a antibody in KCC2b-deficient neurons. One possible cause for the epitope masking
is the binding site of Ste20-related proline-alanine-rich kinase (SPAK) in the KCC2a N-terminus. SPAK, a
known regulator of K-Cl cotransporters, was co-immunoprecipitated in a complex with KCC2a but not
KCC2b isoform. Moreover, SPAK overexpression decreased the transport activity of KCC2a but not that
of KCC2b, as revealed by rubidium flux assay in HEK293 cells. Thus, our data indicate that both KCC2 iso-
forms perform as chloride cotransporters in neuronal cells, while their N-terminal heterogeneity could
play an important role in fine-tuning of the K-Cl transport activity.
 2017 Elsevier B.V. All rights reserved.1. Introduction et al., 2014; Stodberg et al., 2015; Saitsu et al., 2016). KCC2 expres-The neuronal K-Cl cotransporter KCC2 plays a central role in
maintaining the low intracellular chloride concentration required
for the fast hyperpolarizing responses of the inhibitory neurotrans-
mitters GABA and glycine in mature neurons (Kaila et al., 2014).
Mutations in the human gene encoding KCC2 (SLC12A5) are associ-
ated with several epilepsy syndromes (Kahle et al., 2014; Puskarjovsion is strongly up-regulated during neuronal maturation that
leads to the developmental shift in the responses of ionotropic
GABAA and glycine receptors (GABAAR and GlyR) from depolarizing
in immature neurons to hyperpolarizing in adult neurons (Rivera
et al., 1999). Besides the chloride extrusion function, KCC2 is also
known to promote formation and maintenance of dendritic spines
by interacting with the dendritic cytoskeleton (Li et al., 2007; Llano
et al., 2015).
KCC2 has two full-length isoforms, KCC2a and KCC2b, which
differ only in their most N-termini as a result of the alternative
promoter and first exon usage (Uvarov et al., 2007). KCC2b isoform
accounts for about 90% of the total KCC2 expression in the adult
mouse, and about a half of total KCC2 protein in the neonatal
mouse (Uvarov et al., 2009). Both isoforms are expressed in the
developing and adult hypothalamus, brainstem, and spinal cord
(Markkanen et al., 2014). KCC2b expression increases steeply dur-
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brain, while KCC2a expression remains low or absent in the adult
cortex, hippocampus, thalamus, and cerebellum (Markkanen
et al., 2014). In addition to the two full-length KCC2 isoforms, a
number of alternatively spliced truncated KCC2 variants have been
reported (Tao et al., 2012).
Previous studies suggested involvement of the N-terminus of the
K-Cl cotransporters into regulation of the transport activity (Casula
et al., 2001; Shen et al., 2003; Li et al., 2007; Horn et al., 2010;
Fiumelli et al., 2013). The 40-amino-acid long N-terminus unique
for KCC2a contains the binding motif for SPAK (Uvarov et al.,
2007). This SPAK binding sequence RFx(V/I) is also present in N-
terminal domains of other CCC family isoforms (Delpire and
Gagnon, 2008; Richardson et al., 2008) and is evolutionary con-
served, being found in N-termini of KCC2 orthologs in Drosophila
(Hekmat-Scafe et al., 2006) and C. elegans (Tanis et al., 2009). During
the last few years multiple studies have elucidated the important
role of the WNK-SPAK signaling pathway in the regulation of KCC2
transport activity (Inoue et al., 2012; de Los Heros et al., 2014;
Friedel et al., 2015) and for review (Kahle and Delpire, 2016). The
WNK-SPAK signaling pathway was shown to efficiently inhibit the
K-Cl cotransport activity, even though the KCC2b variant, which
lacks the RFx(V/I) motif, was used in most of these studies. This
raises the question whether the SPAK bindingmotif in KCC2a is dis-
pensable for the KCC2 regulation by the WNK-SPAK pathway.
Another open question is whether KCC2a is able to mediate K-Cl
cotransporter activity in mature neurons. While both KCC2 iso-
forms demonstrate similar levels of the chloride transport activity
in HEK293 cells (Uvarov et al., 2007), this has not been demon-
strated in neuronal cells. A functional importance of KCC2a seems
evident since KCC2 null mice that lack both KCC2 isoforms die at
birth (Hubner et al., 2001; Tornberg et al., 2005), while KCC2b-
deficient mice, which retain KCC2a, survive up to three weeks post-
natally (Woo et al., 2002). Yet, KCC2a-deficient mice survive to
adulthood and do not reveal any obvious phenotype (Markkanen
et al., 2014), suggesting that KCC2b can compensate for the lack
of KCC2a. Moreover, although both KCC2 isoforms are expressed
in neonatal spinal motoneurons (Uvarov et al., 2007, 2009;
Markkanen et al., 2014), recordings from KCC2b-deficient mice
demonstrated a more depolarized glycine reversal potential (Stil
et al., 2011) similar to that found in motoneurons of KCC2 null
mice (Hubner et al., 2001). One explanation for that fact could be
the relatively low expression of the KCC2a in the spinal cord: the
KCC2a isoform contributes 20–50% to the total KCC2 protein level
during first postnatal week, decreasing to 20% in adulthood
(Uvarov et al., 2009; Stil et al., 2011). Another reason could be
the attenuated transport activity of KCC2a in the spinal cord
motoneurons as the result of kinetic regulation by protein kinases.
In the current study we attempted to resolve these contradic-
tions. We determined that both KCC2 isoforms are present at the
neuronal surface, and that the KCC2a isoform, similar to KCC2b,
can perform as the functional K-Cl cotransporter to maintain the
low intracellular chloride concentration in neurons. We also found
that the N-terminal epitope of KCC2a but not KCC2b can be masked
at the neuronal plasma membrane, possibly due to the interaction
with SPAK kinase. The differential interaction of the KCC2a and
KCC2b isoforms with SPAK might imply a more stringent control
of the KCC2a isoform by the WNK-SPAK pathway.
2. Results
2.1. Proportion of KCC2a to total KCC2 protein and mRNA expression
decreases gradually with maturation of dissociated cortical cultures
Previous analysis of dissociated cortical neurons derived from
KCC2b-knockout embryos did not reveal any significant decreasein intracellular chloride concentration [Cl]i after 3 weeks in cul-
ture in contrast to the significant decrease of [Cl]i in wild-type
neurons (Zhu et al., 2005). Although that study confirmed the
important role of KCC2b for chloride homeostasis in more mature
cortical neurons, the relative contribution of KCC2a was not
addressed.
To assess the proportion of the KCC2a isoform to the total KCC2
(KCC2a + KCC2b) protein expression in maturing cortical neurons,
we used the previously developed method of running of KCC2a
protein standards (five serial dilutions) on the same SDS-PAGE
alongside with experimental protein lysates (Uvarov et al., 2009).
The KCC2a protein standards contain epitopes for both anti-
KCC2a and anti-KCC2pan antibodies, which are used for the quan-
tification of KCC2a and total KCC2 (KCC2a + KCC2b) expression,
correspondingly. The experimental protein lysates were obtained
from dissociated rat cortical neurons cultured for 2, 8, and 14 days
in vitro (DIV) (n = 3 independent cultures for each time point), and
the KCC2a and total KCC2 levels were assayed by Western blot
using the corresponding antibodies (Fig. 1A). The developmental
expression profiles for KCC2a and KCC2 total were normalized to
b-tubulin and plotted relative to the total KCC2 expression at
DIV2. In agreement with previous reports (Ludwig et al., 2003;
Fiumelli et al., 2005; Zhu et al., 2005; Khirug et al., 2005;
Leonzino et al., 2016), the total KCC2 expression increased 5-
fold during the first week (p < 0.001, Student’s t-test, n = 3) and
3-fold during the second week in culture (between DIV8 and
DIV14, p < 0.001, Student’s t-test, n = 3). Even though KCC2a levels
also increased during the two weeks in culture, the upregulation
was not so pronounced (3.5-fold for the 1st week, p = 0.076;
and 2-fold for the 2nd week, p = 0.046) compared to the total
KCC2 levels (Fig. 1B). The relative proportion of KCC2a to the total
KCC2 protein expression was 40% in DIV2, 30% in DIV8, and
20% in DIV14 dissociated cortical cultures (Fig. 1B). We also ana-
lyzed the expression of SPAK kinase, which is known to regulate
the transport activity of KCC2. SPAK levels rose strongly (4-
fold) between DIV2 and DIV8 points (p = 0.04, Student’s t-test),
but stabilized (p = 0.67, Student’s t-test) during the second week
(Fig. 1B). Thus, the proportion of KCC2a in the total KCC2 expres-
sion decreases gradually during two weeks in culture, while SPAK
expression increases mostly during the first week. The protein data
are in a good agreement with developmental profiles of the KCC2a
and KCC2 total mRNA levels between DIV2 and DIV14 time points
in dissociated cortical cultures, as measured by quantitative real-
time PCR (Fig. 1C). The developmental expression profiles for
KCC2a and KCC2 total were normalized to GAPDH and plotted rel-
ative to the total KCC2 expression at DIV2. KCC2a mRNA levels
increased significantly between DIV2 and DIV8 (3.5-fold,
p < 0.001, Student’s t-test, n = 4), but not later between DIV8 and
DIV14 (1.5-fold, p > 0.05, Student’s t-test, n = 4). In contrast to
KCC2a, the upregulation kinetics of the KCC2pan mRNA levels
was pronounced during the whole time interval (DIV2 to DIV8:
3-fold, p < 0.001, Student’s t-test, n = 4; DIV8 to DIV14: 2-fold,
p < 0.001, Student’s t-test, n = 4).
2.2. KCC2a overexpression promotes active chloride extrusion and
increases EGABA gradient in cultured neurons
The finding that KCC2a isoform constitutes only 20% (or less)
of the total KCC2 expression in the two-week-old cortical cultures
could explain why [Cl]i remains unchanged in the cultured
KCC2b-deficient cortical neurons (Zhu et al., 2005). Indeed, devel-
opmental downregulation of [Cl]i by 15 mM in the wild-type cor-
tical cultures during the same time interval (Zhu et al., 2005) is
normally accompanied by robust 4–5 fold upregulation of the total
KCC2 expression (Ludwig et al., 2003; Fiumelli et al., 2005; Uvarov
et al., 2006). Previous studies have also demonstrated that exoge-
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EGABA reversal potential by 20 mV to more negative values, indi-
cating that high level of KCC2 is a prerequisite for the hyperpolar-
izing GABA responses (Chudotvorova et al., 2005; Liu et al., 2006;
Titz et al., 2015). Therefore, we asked whether KCC2a overexpres-
sion is sufficient to induce the larger EGABA gradient in KCC2-
knockout cortical neurons.
To assess the KCC2a extrusion activity, we used whole-cell
patch-clamp recordings from soma under a constant Cl load via
a somatic patch pipette (Khirug et al., 2005). Each neuron was
stimulated by GABA (uncaging by UV-mediated focal photolysis)
at two locations: a dendritic location and at the soma (Fig. 2A).
Throughout the experiment, NKCC1 was blocked with 10 mM
bumetanide, action potentials with 1 mM TTX, and GABAB receptorswith 1 mM CGP 55845. The difference between the recordings after
stimulations at the soma and dendrite locations (EGABA somatoden-
dritic gradient) can be attributed to Cl extrusion by KCC2, which
leads to the more negative EGABA values in the dendrite relative
to the soma. For our experiments, we used dissociated hippocam-
pal cultures derived from mouse embryos deficient for both KCC2
isoforms (Tornberg et al., 2005). One-week-old KCC2-null neuronal
cultures were cotransfected with KCC2a and EGFP constructs and
analyzed two days after the transfection. Strong KCC2 expression
in the EGFP+KCC2 cotransfected neurons was confirmed by
immunostaining with KCC2pan antibody (Fig. 2B). Efficiency of
the chloride extrusion mediated by KCC2a isoform in the EGFP+
neurons was assessed by measuring the somatodendritic gradient
of reversal potential EGABA (Fig. 2C). As a control, we used KCC2-
null cultures cotransfected with just an empty vector and EGFP.
Resting membrane potential was estimated to be about 65 mV
in both groups. Imposed EGABA gradient was significantly larger
(p < 0.003, Student’s t-test) in the KCC2a-transfected neurons
(0.079 ± 0.007 mV/mm, n = 6) compared to neurons transfected
with the empty vector (0.034 ± 0.009 mV/mm, n = 9) (Fig. 2D).
Thus, KCC2a isoform can mediate effective chloride extrusion
resulting in the significantly augmented somatodendritic EGABA
gradient in the dissociated neuronal cultures.2.3. KCC2a overexpression attenuates depolarizing GABAA responses in
cultured neurons
Since exogenous KCC2a overexpression in cultured neurons
affected EGABA somatodendritic gradient, we asked whether it
could also induce a shift in responses of GABAA receptors from
depolarizing to hyperpolarizing. To address this question, we
recorded calcium responses after application of GABAA receptor
agonist muscimol to the neuronal cultures. The rational for that
experiment was that the depolarizing GABAA responses could
directly activate voltage-gated calcium channels, and thus could
result in the increased intracellular calcium levels (Leinekugel
et al., 1995). To avoid the laborious preparation of KCC2-null cul-
tures, we used wild-type neuronal cultures, but measured
muscimol-responses at DIV6 when endogenous KCC2 expression
is still low (Ludwig et al., 2003; Khirug et al., 2005; Fiumelli
et al., 2005; Uvarov et al., 2006), and GABAA responses are predom-
inantly depolarizing (Chudotvorova et al., 2005; Khirug et al.,
2005). In these and subsequent experiments of this study, we used
dissociated rat cortical cultures as the major model system. The
cultures were transfected with a plasmid expressing either one ofFig. 1. Proportion of KCC2a to the total KCC2 protein and mRNA expression in
maturing dissociated cortical cultures. A) Western blot analysis of KCC2a, KCC2pan
(KCC2a + KCC2b), and SPAK proteins in rat cortical cultures at different time points.
Neuronal marker b-tubulin was used as a loading control to normalize the
expression data. Note that due to limited lower total protein content only 10 mg
was loaded for DIV2 samples. B) Quantification of the Western blot data obtained
from three independent cultures; shown are means (solid circles) and individual
values (empty circles). Total KCC2 (KCC2a + KCC2b) levels grow more rapidly
compared to the KCC2a protein levels during the first two weeks in culture. The
developmental expression profiles for KCC2a and total KCC2 proteins were
normalized to the total KCC2 level at DIV2. At DIV14, 80% of total KCC2 protein
corresponds to KCC2b and 20% to KCC2a. Data are mean ± SEM. (*, p < 0.05; ***,
p < 0.001; ns, not significant, Student’s t-test, n = 3). SPAK expression is upregulated
robustly during the first week in culture, but is stabilized during second week.
Values are mean ± SEM. (*, p < 0.05; ns, not significant, Student’s t-test, n = 3). C)
Quantitative real-time PCR analysis of KCC2a and KCC2 total mRNA expression
relative to GAPDH in DIV2, DIV8 and DIV14 dissociated cortical cultures. The
developmental mRNA expression profiles for KCC2a and KCC2 total were normal-
ized to GAPDH and plotted relative to the total KCC2 expression at DIV2. Means
(solid circles) and individual values (empty circles) are shown. Data are mean ± -
SEM. (*, p < 0.05; ***, p < 0.001; ns, not significant, Student’s t-test, n = 4).
3
Fig. 2. KCC2a is functional in transfected culturedhippocampal neurons. The efficacy of K-Cl cotransportmediated byKCC2awas determinedby estimating its capacity to induce
a somatodendritic chloride gradient in DIV10 neurons from KCC2-null mutant mice co-transfected at DIV8 with KCC2a (and EGFP) or control (EGFP only) expression vector. A)
Schematic depictionof themethod,which includeswhole-cell patch-clamp recordings under a constant Cl load via a somatic patchpipette. KCC2molecules aredepictedbygray
circles at the surface of the soma and dendrite. Recordings were done always from soma, but GABA uncaging (by UV-mediated focal photolysis) was done for each neuron
consequently at the soma and at a proximal dendritic location. B) Shown is a wide-field image of immunostaining with KCC2pan antibody of a KCC2a-transfected neuron
expressing KCC2a in the soma and dendrites. Two insets on the right are overexposed from the same image (marked by rectangles) and allow comparing levels of
immunoreactivity produced by the KCC2pan antibody in the KCC2a-transfected neuron and in the neighbor non-transfected KCC2-KOneuron (marked by the asterisk). Scale bar
is 20 lm.C)Whole-cell patch-clamp recordings under a constant Cl load via a somatic patchpipettewere used to assess an imposed EGABA somatodendritic gradient. Recordings
were performed always from soma, but GABA uncaging (marked by line above the traces) was done separately at the soma and at the proximal dendritic location. Shown are
typical traces and I-V plots of theGABAA responses of uncaging at the soma (j, bottom right traces) and at the dendrite (h, top left traces) of a neuron transfectedwith KCC2a (left
panel) and a control neuron transfected with EGFP only (right panel). I–V curves were plotted based on the specimen recordings shown in the insets, and were normalized with
respect to peak IGABA at the most negative holding potential (Vh) tested in the experiment. D) The histogram shows the imposed somatodendritic gradient of EGABA in the
hippocampal neurons (fromKCC2-nullmutantmice) transfectedwithKCC2a or control vector. Values aremean ± SEM. (**, p < 0.01, Student’s t-test; number of analyzedneurons
is indicated under the corresponding bars).
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expressing construct was cotransfected to designate targeted neu-
rons (Fig. 3A). Calcium transients were recorded using Fura-2 AM
calcium imaging protocol in EGFP-positive as well as in EGFP-
negative neurons after application of 50 mM GABAA receptor ago-
nist muscimol (Fig. 3B). After washing out muscimol, the extracel-
lular solution with zero potassium concentration was applied and
Ca2+ responses were recorded. It has been reported previously thatthe extracellular solution with the low potassium concentration
([K+]o < 0.2 mM) was able to induce Ca2+ responses in glial cells
but not in neurons (Dallwig et al., 2000; Dallwig and Deitmer,
2002). Thus, we used this step to distinguish neurons and astro-
cytes. Finally, the solution with low potassium was replaced with
extracellular solution containing 50 mM KCl and Ca2+ responses
were recorded to confirm neuronal vitality. Only those cells that
responded to 50 mM KCl, but not to zero [K+]o application, were
taken into account for further analysis.
Above 60% of neurons transfected with the empty vector
(66 ± 4%, n = 35) responded with Ca2+ transients upon muscimol
application (Fig. 3C), and this ratio was similar to that detected
in untransfected cells (70 ± 4%, n = 358). These results indicate that
the endogenous KCC2 activity in the majority of one-week-old cul-
tured cortical neurons was not high enough to maintain the low
[Cl]i level required for hyperpolarizing GABA responses. Overex-
pression of either KCC2a or KCC2b isoform caused a dramatic
decrease in the fraction of responding neurons down to 15%
(KCC2a: 13 ± 8%, n = 28 neurons; KCC2b: 13 ± 7%, n = 25)
(Fig. 3C). There were no significant difference between KCC2a or
KCC2b isoforms, while the difference for both KCC2 variants com-
pared to vector (or untransfected) was significant (p < 0.001,
ANOVA, Bonferroni multiple comparisons test). Thus, both KCC2
variants efficiently ceased the depolarizing responses of GABAA
receptors. These results ensured that the KCC2a isoform is active
in transfected cultured neurons and can reduce the intracellular
chloride concentration to the level sufficient for attenuating the
depolarizing responses of the GABAA receptors.2.4. Subcellular distribution and membrane localization of the KCC2
isoforms in cultured neurons
Even though the exogenous KCC2a promotes chloride extrusion
in the KCC2-null neurons (Fig. 2) as well as in the immature wild-
type neurons (Fig. 3), functionality of the endogenous KCC2a can-
not be concluded solely based on overexpression experiments.
For example, the forced KCC2a overexpression may overcome
putative mechanisms that normally prevent KCC2a trafficking to
the neuronal plasma membrane. To assess the functionality of
the endogenous KCC2 isoforms, their subcellular distribution and
surface expression was examined in two-week-old dissociated
rat cortical cultures by immunostaining with the KCC2a and KCC2b
antibodies (Fig. 4A). At that time point, KCC2b staining was
observed in all neurons, and in about half of them KCC2b signal
was observed nearby the plasma membrane, i.e., the signal out-
lined the soma and proximal dendrites while the cytoplasm was3
Fig. 3. KCC2a overexpression attenuates depolarizing GABAA responses in cultured
neurons. A) Four images for a typical Fura-2 AM calcium imaging protocol are
shown: bright field image of a whole optical field (upper left); the same optical field
obtained with GFP-filter for identification of transfected cells (upper right); Fura-
340 signal, which was weak due to usage of suboptimum 10x objective lens (lower
left), and Fura-380 signal, which was used for subsequent analysis (lower right).
Regions of interest (ROIs) chosen for cell soma regions are shown for the GFP-
positive cells (yellow circles, ROI1-ROI7). Scale bar is 100 mm. B) Muscimol induces
Ca2+ increase in the cortical neurons. To discriminate between glial cells and
neurons, we used a previously described protocol that takes into account their
different Ca2+ responses on application of low external [K+] (Dallwig and Deitmer,
2002). Exogenous KCC2a and KCC2b prevent the Ca2+ increase induced by
muscimol. Shown are representative responses of individual cells from different
transfections. C) Quantification of the calcium responses in DIV6 cortical cultures
shows that overexpression of KCC2a and KCC2b attenuates the muscimol-elicited
depolarizing GABA responses. Number of independent experiments (plates) ana-
lyzed is indicated. The number of cells measured in each plate was 20–40. Values
are means (±SEM) of percentile (% of responding cells in each plate). (***, p < 0.001,
ANOVA, Bonferroni multiple comparisons test, ns = not significant).
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reveal any near-surface expression, and KCC2a immunoreactivity
was detected exclusively in the intracellular compartments
(Fig. 4A). These data are in agreement with our previous report that
failed to detect endogenous KCC2a immunoreactivity at the neu-
ronal plasma membrane in vivo in several brain regions with high
KCC2a expression (Markkanen et al., 2014).
Since biotinylation assay is an established method to assess sur-
face expression of membrane proteins, we used it to compare the
membrane expression of KCC2a and KCC2b variants in 2-week-oldcortical neurons. Biotin labeling and subsequent Western blot analy-
sis with KCC2a and KCC2b antibodies demonstrated that the relative
surface representation of KCC2a and KCC2b isoforms (monomers)
was about 40% of the total expression level for each of the isoforms
(Fig. 4B and C). Neuronal b-tubulin protein, known to be exclusively
cytoplasmic, was not detected in the biotinylated fraction, proving
correctness of our biotinylation procedure.
Taken together, the immunostaining data show that both KCC2a
and KCC2b are consistently observed in neuronal soma and den-
drites. In two-week-old cultures, KCC2b but not KCC2a immunore-
activity is observed nearby the plasma membrane surface of soma
and dendrites. Yet, the biotinylation experiments clearly indicate
that both isoforms are expressed to similar extent at the neuronal
plasma membrane. This discrepancy between the immunostaining
and biotinylation data suggests that the N-terminal epitope of
KCC2a may be masked at the plasma membrane.
2.5. KCC2a expression at the cell surface is detected by the KCC2a
antibody in certain brain areas
In our previous study, we examined the KCC2a subcellular
localization in several areas of adult mouse CNS with high KCC2a
expression (brainstem, midbrain, and spinal cord), but failed to
observe clear plasma membrane localization of the KCC2a
immunoreactivity, whereas KCC2b labeling was observed nearby
somatic plasma membrane in virtually all analyzed regions
(Markkanen et al., 2014). In the current study, we analyzed KCC2a
surface expression in additional brain areas with medium level of
KCC2a expression. Brain sections of wild-type, PFA-fixed adult
mice were double-labelled with KCC2a and KCC2b antibodies,
and KCC2a expression was clearly seen in the subiculum, a part
of the hippocampal formation, but not in the nearby CA1 area
(Fig. 5A). In contrast, KCC2b staining was found throughout hip-
pocampus formation, as reported previously (Fig. 5A). Confocal
images revealed KCC2a labeling nearby neuronal soma surface in
the subiculum and a somewhat less clear signal at the surface of
hypothalamic neurons (Fig. 5B). In both cases, KCC2b labeling
was clearly detected nearby the soma surface. Similar to our previ-
ous data from pons and deep cerebellar nuclei (Markkanen et al.,
2014), KCC2b but not KCC2a labeling was detected at the plasma
membrane of neuronal somas in the medulla oblongata (Fig. 5B).
KCC2b immunostaining was localized at the neuronal plasma
membrane in all brain areas (including hippocampus and cortex)
and similarly in KCC2a-deficient (Suppl. Fig. 1) and wild-type mice
(Fig. 5 and Suppl. Fig. 2). Thus, different regions of the adult mouse
brain demonstrate different levels of KCC2a plasma membrane3
Fig. 4. Subcellular localization of endogenous KCC2a and KCC2b in primary
neuronal cultures A) Endogenous expression of KCC2 isoforms in methanol fixed
dissociated cortical cultures derived from E18 rat embryos and cultured for two
weeks in vitro (DIV14). Pseudocolor images of cortical neurons immunostained with
antibodies against KCC2a or KCC2b are shown. Pseudocolors were designated as red
(highest expression) to dark blue (lowest expression). KCC2b immunoreactivity is
localized nearby the cell surface, but signal is also seen in intracellular compart-
ments in the soma region as well as in dendrites. In parallel cultures immunos-
tained with KCC2a antibodies, the immunoreactivity is mainly intracellular within
soma and dendrites. The optical section images were acquired with a 63 oil-
immersion objective under a Zeiss LSM5 Pascal confocal microscope. Scale bar is
10 lm. B) Cell surface expression of KCC2 isoforms was studied in dissociated
cortical cultures with a biotinylation assay. Cells were derived from E18 rat
embryos and cultured for two weeks in vitro (DIV12). Surface-expressed proteins
(and total protein) were detected by immunoblot analysis with antibodies to
KCC2a, KCC2b and KCC2pan antibodies (and b-tubulin antibodies as a control). C)
Quantification of the biotinylated band intensities normalized to the total band
intensities demonstrated that 40% of total endogenous KCC2a as well as KCC2b
(monomers) are expressed on the surface. (n = 3).
Fig. 5. KCC2a immunoreactivity is detected at the somatic surface in certain mouse
brain areas. A) In PFA-fixed wild-type adult mouse brain sections double-labeled
with antibodies to KCC2a and KCC2b, KCC2a-labeling is seen only in the subiculum
(marked with asterisk), whereas KCC2b staining is found throughout the hip-
pocampal formation. The wide-field fluorescence images were obtained by using a
10 objective under a Zeiss Axioplan 2 microscope and an Axiocam HR camera.
Scale bar is 500 lm. B) Confocal images from subiculum (from the location marked
with an asterisk in A), hypothalamus and medulla are shown. Somas (asterisks) and
dendrites (arrows) are marked in the merged images. KCC2a signal (green) can be
observed nearby the surface of somas and dendrites in subiculum and hypotha-
lamus. However, in the medulla KCC2a is not visible nearby the soma surface, in
contrast to KCC2b (red). In the putative dendritic profiles, KCC2a and KCC2b signals
are not completely colocalized (yellow in merged images). The optical section
images were acquired with a 40 (NA 1.2) water-immersion objective under a Leica
TCS SP8 confocal microscope. Scale bar is 20 lm.
Fig. 6. SPAK reveals higher binding affinity to KCC2a than to KCC2b isoform. A)
Conservation of the putative SPAK binding site of KCC2a among CCC family
members. The N-terminal part of KCC1 contains a similar amino acid sequence
HFTV, which has been shown to bind OSR1 (Austin et al., 2014). KCC4a isoform
containing SPAK/OSR1-binding motif has been predicted previously (Uvarov, 2010).
B) KCC2a or KCC2b expression vectors (or an empty vector) were co-expressed with
an HA-tagged SPAK expression vector (HA-SPAK) in HEK293 cells. Forty-eight hours
after the transfection, the cells were lysed and subjected to co-immunoprecipitation
(coIP) with KCC2pan antibodies (IP: KCC2pan). Binding partners of the KCC2a and
KCC2b proteins were analyzed by Western blot with the indicated antibodies (IB).
The KCC2pan antibody efficiently precipitated both KCC2a and KCC2b proteins from
the cell lysates (upper panel of the IP: KCC2pan part). The HA-SPAK protein was
detected from cells co-expressing HA-SPAK and KCC2a, but not from cells co-
expressing HA-SPAK and KCC2b (lower panel of the IP: KCC2pan part). The presence
of KCC2a, KCC2b, and HA-SPAK proteins in the lysates was confirmed with the
corresponding antibodies (Input). C) CoIP with the anti-HA antibody (IP: HA) and
detection with KCC2a confirm that KCC2a can interact with HA-SPAK (middle panel
of the IP: HA part). Note that the KCC2 isoforms detected after coIP with HA were
mostly of higher order associates (asterisk), possibly due to the KCC2 aggregation
induced by heating (required for dissociation of the precipitated protein complexes
from the beads). Expression of KCC2a, KCC2b, and HA-SPAK proteins in the cell
lysates is also shown (Input).
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tially high in the hypothalamus and subiculum. In contrast, KCC2b
immunoreactivity is seen at the neuronal soma surface practically
in all analyzed brain areas.
2.6. SPAK reveals higher affinity to KCC2a compared to KCC2b
One possible explanation for the KCC2a epitope masking is the
canonical SPAK/OSR1 binding motif found in the N-terminus of the
KCC2a isoform (Uvarov et al., 2007). The canonical SPAK/OSR1binding motif RFx(V/I) is present in at least one splice variant of
each mammalian CCC family member, except KCC1 (Fig. 6A). To
examine whether SPAK interacts differentially with KCC2a isoform
carrying the RFx(V/I) motif, and KCC2b, which lacks such motif, we
used co-immunoprecipitation assay. The hemagglutinin-tagged
SPAK protein (HA-SPAK) was co-expressed with either KCC2a or
KCC2b in HEK293 cells; as a negative control, SPAK was co-
expressed with an empty expression vector. The protein complexes
were immunoprecipitated using KCC2pan antibody, which recog-
nizes C-terminal domain common for both isoforms. Since KCC2a
and KCC2b isoforms possess identical C-termini, we assumed that
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forms. Indeed, KCC2a and KCC2b proteins were both efficiently
immunoprecipitated by KCC2pan antibody, while no KCC2 was
detected in the negative control lysate (empty expression vector)
(Fig. 6B, the first top panel), thus corroborating the absence of
endogenous KCC2 expression in HEK293 cells (Payne et al., 1996;
Williams et al., 1999). In agreement with presence of SPAK-
binding motif in KCC2a but not in KCC2b isoform, immunoblotting
with anti-HA antibody revealed the strong signal corresponding to
the co-precipitated SPAK in lysates obtained from HEK293 cells
transfected with KCC2a (Fig. 6B, the second top panel). In contrast,
only weak background signals were observed in the KCC2b and the
control lysates. Additional analysis of input samples confirmed
equal SPAK expression in all three samples; KCC2a and KCC2b
expression in the input samples also were similar (Fig. 6B, the third
and fifth panels).
To confirm above results, we reversed co-immunoprecipitation
assay and used anti-HA antibody to precipitate protein complexes
from the same HEK293 lysates (Fig. 6C). Precipitation with the
anti-HA antibody was not as effective as with the KCC2pan
antibody, yet detectable HA-SPAK enrichment was observed
(Fig. 6C, the first top panel). The precipitated complexes contained
KCC2a, as revealed by immunoblotting with KCC2a antibody
(Fig. 6C, the second top panel), indicating that SPAK binds KCC2a
in the heterologous expression system. The KCC2pan antibody
was also able to detect a clear band corresponding to the dimeric
KCC2a isoform, but only a more diffuse band in the KCC2b-
expressing sample (Fig. 6C, the third panel). Detection of the
monomeric KCC2 isoforms in the immunoprecipitated complexes
was prevented by the previously described irreversible KCC2
aggregation upon heating protein lysates at temperatures higher
than 70 C (Blaesse et al., 2006; Uvarov et al., 2009). Indeed, the
procedure of stripping the protein complexes from agarose beads
after immunoprecipitation includes heating of the precipitated
samples at 95 C for 5 min, while the notable KCC2 aggregation
starts already at temperatures above 60 C that leads to fading of
the KCC2 monomeric band (Suppl. Fig. 3). Additional analysis of
the input samples revealed equal levels of SPAK in all lysates,
and similar expression level for KCC2a and KCC2b proteins in the
lysates transfected with the corresponding expression vectors
(Fig. 6C, Input panels). Thus, co-immunoprecipitation data demon-
strated that SPAK interaction with KCC2a, which has SPAK/OSR1
binding consensus, is substantially stronger than that with KCC2b,
which lacks such motif.Fig. 7. SPAK inhibits the furosemide-sensitive 86Rb uptake mediated by KCC2a. A)
Immunocytochemistry with antibodies to KCC2pan in methanol-fixed HEK cells
overexpressing KCC2a and KCC2b shows that both isoforms are located nearby the
cell surface (red). Images are shown with blue DAPI stained nuclei (left) and
without DAPI (right). The optical section images were acquired with a 63 oil-
immersion objective under a Zeiss LSM5 Pascal confocal microscope. Scale bar is
10 mm. B) Furosemide-sensitive 86Rb uptake was measured in HEK293 cells
transfected with KCC2a, KCC2b, or empty vector plasmids. Bumetanide (10 lM)
and ouabain (100 lM) were added to prevent 86Rb flux through NKCC1 and Na/K-
ATPase, respectively. Furosemide-sensitive 86Rb uptake was more than 30 times
higher in cells expressing KCC2a or KCC2b than in cells transfected with an empty
vector. Values are mean ± SEM. (*p < 0.05, ANOVA, Bonferroni multiple comparisons
test, n = 4). Representative autoradiography images of the wells containing mono-
layers of HEK293 cells after the 86Rb uptake are shown below (see Methods). C) Co-
expression of KCC2a and SPAK (left panel, grey bar) resulted in significant
downregulation of the furosemide-sensitive 86Rb uptake compared to cells
cotransfected with KCC2a and empty vector (left panel, open bar) (81 ± 6%,
*p < 0.05 compared with KCC2a control, one-sample t-test, n = 6). Co-expression
of KCC2b with SPAK (right panel, grey bar) did not significantly change the
furosemide-sensitive 86Rb uptake compared with KCC2b control (right panel, open
bar) (109 ± 9%, p > 0.05, one-sample t-test, n = 6). However, co-expression with DN-
SPAK increased both KCC2a (left panel, filled bar) (*, p < 0.05 compared with KCC2a
control, one-sample t-test, n = 6) and KCC2b-mediated 86Rb uptake (right panel,
filled bar) (**, p < 0.01 compared with KCC2b control, one-sample t-test, n = 6).
"
2.7. SPAK differently regulates kinetic activity of KCC2a and KCC2b
isoforms in HEK293 cells
Previous reports have pointed at the important role of SPAK and
OSR1 kinases in regulation of CCC family members: both kinases
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proteins (Alessi et al., 2014). Given the differential interaction of
SPAK with KCC2a and KCC2b isoforms, we asked whether this
could also result in differential regulation of the chloride transport
activity of the KCC2 variants by SPAK. To answer this question, we
utilized the functional 86Rb assay in HEK293 cells, which are
known to express endogenously KCC1, KCC4, and NKCC1 proteins
(Xu et al., 1994; Simard et al., 2007), but neither KCC2a nor KCC2b
isoforms (Payne, 1997; Uvarov et al., 2009). Functional 86Rb assay
is a direct method for measuring the activity of potassium channels
and transporters, since K+ cation can be substituted by its radioac-
tive congener – 86Rb+ (Bartschat and Blaustein, 1985). Thus, the
transport activity can be assessed by quantifying the accumulation
of radioactive 86Rb in the cells. Rubidium assay was performed to
measure the influx (not efflux) mode of the KCC2 transport activity
as described previously (Payne, 1997; Uvarov et al., 2007). The
inversed mode of KCC2 transport activity is induced by increasing
the extracellular K+ (or 86Rb+) concentration up to 5 mM (Payne,
1997).
We transiently transfected HEK293 cells with constructs encod-
ing either KCC2a or KCC2b isoforms and confirmed their expres-
sion at the plasma membrane by immunostaining with
antibodies to KCC2pan (red) (Fig. 7A; nuclei are labeled by DAPI
(blue)). The 86Rb+ flux was measured with and without furosemide
(2 mM), a well-known inhibitor of KCC cotransporters, to deter-
mine the furosemide-sensitive component of the K-Cl transport
activity mediated by the KCC2a and KCC2b variants. Bumetanide
(10 mM), a potent inhibitor of the endogenously expressed NKCC1
protein (Xu et al., 1994), was added into all flux solutions to
exclude NKCC1 impact on 86Rb uptake. Transient overexpression
of either KCC2 variant increased the furosemide-sensitive 86Rb
uptake by 35-fold compared to control HEK293 cells transfected
with empty vector (Fig. 7B). This is in agreement with previous
results showing that KCC2a and KCC2b proteins mediate similar
86Rb uptake in isotonic conditions (Uvarov et al., 2007). Co-
expression of SPAK with KCC2a isoform decreased the
furosemide-sensitive 86Rb uptake by 20% (81 ± 6%, p < 0.05,
one-sample t-test, n = 6) compared to uptake by cells cotransfected
with KCC2a and a control empty vector (Fig. 7C). In contrast, SPAK
co-expression with KCC2b did not change the furosemide-sensitive
86Rb uptake compared to uptake by control cells transfected with
KCC2b only (109 ± 9%, p > 0.05, one-sample t-test, n = 6).
It has been shown previously that SPAK and OSR1 kinases can
be activated by low [Cl]i (Gagnon et al., 2006a; Richardson
et al., 2008; de Los Heros et al., 2014). This suggests that the
endogenous SPAK/OSR1 in HEK293 cells could be activated upon
KCC2a/KCC2b transfection. To test whether KCC2a and KCC2b iso-
forms are regulated by endogenous SPAK/OSR1 in HEK293 cells, we
overexpressed the kinase-inactive K101R mutant form of SPAK
(DNSPAK), which can interact with SPAK/OSR1-binding motif in
target proteins, but is unable to phosphorylate the targets (Dowd
and Forbush, 2003). As expected, DNSPAK overexpression strongly
(3.2-fold) enhanced the KCC2a-mediated furosemide-sensitive
86Rb uptake (220 ± 70%, p < 0.05, Student’s t-test, n = 6) relative
to the cells transfected with KCC2a construct only (Fig. 7C). Inter-
estingly, DNSPAK also upregulated (2.6-fold) the KCC2b mediated
furosemide-sensitive 86Rb uptake (160 ± 20%, p < 0.01, Student’s
t-test, n = 6).3. Discussion
The main findings of this paper are: 1) overexpressed KCC2a
isoform is active in cultured neurons, 2) endogenous KCC2a is pre-
sent at the neuronal plasma membrane but its N-terminal epitope
can be masked, and 3) SPAK binds and inhibits KCC2a.The functionality of the KCC2b isoform is well-established
(Rivera et al., 1999), but data regarding the KCC2a role in neurons
has remained elusive. Importance of KCC2a is inferred from the
comparisons of mice lacking both KCC2 isoforms that cannot main-
tain respiratory rhythm and die immediately after birth (Hubner
et al., 2001), and mice deficient for the KCC2b isoform (and retain-
ing KCC2a) that survive postnatally for three weeks (Woo et al.,
2002). Yet, adult KCC2a-deficient mice show no obvious gross neu-
rological phenotype (Markkanen et al., 2014). In this study, we
have examined three working hypotheses to explain this apparent
controversy: (1) KCC2a protein expression in two-week-old cul-
tures may be too low to affect the intracellular chloride concentra-
tion, (2) KCC2a traffic to the plasma membrane may be impeded,
and (3) KCC2a transport activity may be inhibited by mechanisms
that have been shown previously to regulate activity of KCC2
(Alessi et al., 2014; Kahle and Delpire, 2016).
First, we established that the relative KCC2a expression is
indeed low in the dissociated cortical neurons and constitutes only
about 20% of the total KCC2 expression in two-week old cultures.
Previous reports have estimated the relative contribution of KCC2a
to the total KCC2 expression in the mouse cortex as 60% at birth,
gradually decreasing to 15% in two-week old pups, and to 10%
in adult mice (Woo et al., 2002; Uvarov et al., 2007, 2009). Similar
values (20%) were observed in the mouse spinal cord during first
postnatal week (Stil et al., 2011). This low level of expression could
explain why the remaining KCC2a expression in the KCC2b-
deficient mice is not sufficient for maintaining the hyperpolarizing
responses of glycine receptors in spinal motoneurons (Stil et al.,
2011) or GABAA receptors in cortical neurons (Zhu et al., 2005),
resulting in seizures and lethality three weeks after birth (Woo
et al., 2002). Indeed, the developmental shift in the GABAA receptor
responses is accompanied by the robust increase in the KCC2
expression in maturing neurons (Rivera et al., 1999; Fiumelli
et al., 2005; Zhu et al., 2005; Khirug et al., 2005; Uvarov et al.,
2006; Leonzino et al., 2016), mainly due to the upregulation of
the KCC2b isoform (Uvarov et al., 2009).
KCC2b overexpression in immature cultured neurons produces
a substantial negative shift in the GABA reversal potential and
strongly attenuates GABA-elicited calcium responses
(Chudotvorova et al., 2005; Lee et al., 2005; Liu et al., 2006). In
the present study, we found that the overexpression of KCC2a
increased the somatodendritic EGABA gradient in the dissociated
hippocampal neurons derived from the KCC2-null embryos.
Moreover, KCC2a overexpression in immature wild-type cortical
neurons decreased the fraction of neurons that showed
muscimol-induced Ca2+-transients. Taken together, overexpressed
KCC2a, similar to KCC2b, is active in neuronal cells under isotonic
conditions. This corroborates previous observations attributing the
unique ability of KCC2 to work in isotonic conditions to the
C-terminal ISO domain (Mercado et al., 2006; Acton et al., 2012)
that is identical in KCC2a and KCC2b isoforms.
Functionality of the endogenous KCC2a cannot be concluded
solely based on overexpression experiments. For example, the
forced KCC2a overexpression may overcome putative control
mechanisms that normally prevent KCC2a trafficking to the neu-
ronal plasma membrane. Our previous report failed to detect
endogenous KCC2a immunoreactivity at the neuronal plasma
membrane in several brain regions with high KCC2a expression
(Markkanen et al., 2014). Similarly, in the present study, endoge-
nous KCC2a immunoreactivity was detected mainly intracellularly
in cortical neurons cultured for two weeks, while KCC2b
immunoreactivity was predominantly observed nearby the plasma
membrane. Similar results were observed in cultured mouse hip-
pocampal neurons (Suppl. Fig. 4). Surprisingly, in contrast to the
immunostaining data, our biotinylation assays clearly showed that
both KCC2 isoforms are similarly present at the plasma membrane
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KCC2a N-terminal epitope, which is recognized by the KCC2a anti-
body, could be masked. To test this hypothesis further, we used
KCC2b-deficient mice (Woo et al., 2002), in which KCC2a remains
the only expressed KCC2 isoform (Uvarov et al., 2007). Immunos-
tainings of brain sections obtained from these mice with KCC2pan
antibody, which recognizes the common C-terminus of KCC2
(Williams et al., 1999), indeed demonstrated immunoreactivity
nearby the plasma membrane, while the KCC2a immunoreactivity
was still intracellular (Suppl. Fig. 5). We re-examined our previous
immunostaining data obtained with KCC2a and KCC2b antibodies
from brain sections of adult wild-type mice (Markkanen et al.,
2014). This analysis confirmed our previous observations that
KCC2a immunoreactivity is predominantly intracellular in most
analyzed brain areas. However, we did find clear near-surface
expression of KCC2a in the subiculum and less prominent near-
surface expression in some hypothalamic areas. In contrast, KCC2b
immunostaining was localized at the neuronal plasma membrane
in all brain areas and similarly in KCC2a-deficient (Suppl. Fig. 1)
as in wild-type mice (Fig. 5 and Suppl. Fig. 2). The reason for the
KCC2a epitope masking remains unclear at present, but could for
example be due to heterodimerization since KCC2a and KCC2b
immunoreactivities clearly overlap in several areas as seen in con-
focal images presented in Fig. 5B. Previous reports have shown that
KCC2a and KCC2b isoforms can form oligomers (Blaesse et al.,
2006; Uvarov et al., 2009; Mahadevan et al., 2014). Also clustering
in lipid rafts may play a role in the KCC2a epitope masking as pre-
vious reports have shown that KCC2 can be detected in lipid rafts
(Watanabe et al., 2009; Hartmann et al., 2009).
Epitope masking could also result from expression of protein(s)
that bind the N-terminal epitope. An obvious candidate for the
KCC2a epitope masking is the Ste20-related proline alanine rich
kinase (SPAK alias STK39). The binding motif RFx(V/I) for SPAK
(or its homologue oxidative stress responsive kinase, OSR1) is
located in the unique N-terminal part of the KCC2a (Uvarov
et al., 2007). In agreement with existence of the motif in KCC2a
but not in KCC2b, we show that SPAK binds preferentially KCC2a
but not KCC2b isoform in the heterologous HEK293 expression sys-
tem. Although the SPAK binding motif (residues 4–7) is outside the
KCC2a antibody binding epitope (residues 20–40), the dimeric
domain-swapped structures of SPAK and OSR1 kinases (Lee et al.,
2009; Taylor et al., 2015) and their reported crystal structures in
complex with RFxV containing peptides (Villa et al., 2007; Taylor
et al., 2015) suggest that the epitope could become sterically hid-
den by the large dimeric SPAK kinase complex. The heterogeneous
expression pattern of SPAK protein (Ushiro et al., 1998; Johnston
et al., 2000; Piechotta et al., 2003) and mRNA (Allen Brain Atlas)
in the mouse brain could also explain why KCC2a immunoreactiv-
ity is detected nearby neuronal surface in some but not other brain
regions. Testing this hypothesis by comparing the co-localization
of KCC2a and SPAK was hindered by lack of good antibodies suit-
able for immunohistochemistry. However, analysis of SPAK mRNA
expression pattern in adult mouse brain revealed a low expression
level of SPAK in subiculum and hypothalamus, while much stron-
ger expression could be seen in deep cerebellar nucleus or medulla
(Suppl. Fig. 6), thus supporting our hypothesis. In addition, SPAK
can be rapidly translocated from cytosol into cytoskeletal fraction
under osmotic, oxidative or high temperature stress (Ushiro
et al., 1998; Tsutsumi et al., 2000). We speculate that this regula-
tion of SPAK distribution between the cytosol and cytoskeleton
could also be involved in the differential plasma membrane
expression of KCC2a immunoreactivity in different brain regions.
However, the physiological relevance of this remains to be studied.
The a2-subunit of Na+/K+-ATPase (NKA) is also a possible can-
didate for the role of the N-terminal ‘‘masker”, as previous datahave demonstrated physical interaction between KCC2 and a2-
subunit of NKA (Ikeda et al., 2004). Ikeda and coauthors have also
highlighted a similarity between KCC2 and NKA expression pat-
terns. In their co-IP experiments the authors used an antibody pro-
duced against a short C-terminal fragment of KCC2
(CDNEEKPEEEVQLIH, 961–975 aa of the mouse KCC2 sequence)
identical in KCC2a and KCC2b, thus leaving open the question
which KCC2 isoform interacts with NKA. Interestingly, another
member of the K-Cl cotransporter subfamily – KCC3a – has
recently been shown to interact with the a1-subunit of NKA
(Fujii et al., 2008). Moreover, KCC2 and NKA have been shown to
colocalize in chicken heart, where KCC2a is the only expressed iso-
form (Antrobus et al., 2012).
Since OSR1 protein expression level is much lower compared to
SPAK in mouse brain (Geng et al., 2009), we concentrated on KCC2
regulation by SPAK. To study regulation of the KCC2a and KCC2b
transport activities by SPAK, we chose HEK293 cells, which have
been extensively used for studying SPAK-mediated regulation of
cation-chloride cotransporters. HEK293 cells express endoge-
nously KCC1, KCC4, and NKCC1 proteins (Xu et al., 1994; Simard
et al., 2007), but neither KCC2a nor KCC2b (Payne, 1997; Uvarov
et al., 2009). Previously we found that exogenous KCC2a overex-
pression results in the furosemide-sensitive efficient chloride flux
in HEK cells (Uvarov et al., 2007). In the present study, we con-
firmed trafficking of both KCC2 isoforms to the plasma membrane
after exogenous overexpression and significant increase of the
furosemide-sensitive 86Rb uptake. The potent NKCC1 inhibitor
bumetanide was added to all solutions to exclude NKCC1-
mediated 86Rb flux. The impact of the endogenous KCC1 and
KCC4 cotransporters was low as determined from values of 86Rb
flux in the control cells transfected with empty vector. It is impor-
tant to note that SPAK and OSR1 kinases, as well as their upstream
kinase WNK1, are expressed endogenously in HEK293 cells (Vitari
et al., 2006; Rinehart et al., 2009). Thus, it is possible that overex-
pressed KCC2a (or KCC2b) will be exposed to regulation mediated
by endogenous SPAK. This could partly explain the rather moderate
inhibition (20%) of the furosemide-sensitive 86Rb flux after the
exogenous SPAK overexpression in the HEK293 cells co-
expressing KCC2a, compared to the cells overexpressing KCC2a
only. The relatively mild effect of the exogenous SPAK overexpres-
sion on the KCC2a activity in our experiments could also be caused
by the absence of the MO25 coactivator, which has been reported
to dramatically (100-fold) enhance the ability of SPAK/OSR1 to
directly phosphorylate KCC2a and other cotransporters in bio-
chemical assays (Filippi et al., 2011; de Los Heros et al., 2014). Nev-
ertheless, in contrast to KCC2a, we did not detect any effect of SPAK
overexpression on the transport activity of the KCC2b isoform.
Although SPAK expression (in oocytes) has been shown previously
to inhibit KCC2b transport activity in hypotonic/low chloride con-
ditions (Gagnon et al., 2006b), we speculate that since the experi-
ment was performed in isotonic solution (and without adding
WNKs or MO25 coactivator), SPAK activity was probably relatively
low, and thus inhibition of KCC2b was not detected. Previous data
have also failed to reveal KCC2b inhibition in isotonic conditions
after SPAK overexpression in the absence of WNKs (Gagnon
et al., 2006b).
Multiple serine (Ser78, Ser83) and threonine (Thr6, Thr77, Thr92,
Thr929, and Thr1030) residues in KCC2a isoform have been reported
as phosphorylation targets of the SPAK kinase (de Los Heros et al.,
2014). Since KCC2a possess only 40 unique amino acids, all these
phosphorylation sites except Thr6 are also present in KCC2b. Thus,
both KCC2 isoforms could possibly be phosphorylated by endoge-
nous SPAK in HEK293 cells even without exogenous SPAK overex-
pression. Consistent with this it has been shown previously that
the C-terminal part of KCC2b isoform is affected by WNK-SPAK
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2015), even though the KCC2b isoform lacks the SPAK-binding
motif.
To test whether KCC2a and KCC2b isoforms are regulated by
endogenous SPAK/OSR1 in HEK293 cells, we overexpressed the
dominant negative SPAK (DNSPAK) (Dowd and Forbush, 2003).
This DNSPAK contains a single amino acid substitution (K101R)
within the catalytic domain that impairs its kinase activity. Thus,
DNSPAK can bind proteins at the same sites as SPAK, but cannot
phosphorylate them. The exact outcome of the DNSPAK binding
to target proteins is not obvious except that it prevents their phos-
phorylation. For example, possible conformation changes of the
target proteins after DNSPAK binding cannot be excluded.
In our experiment, DNSPAK overexpression strongly enhanced
the furosemide-sensitive 86Rb uptake mediated by both KCC2a
and KCC2b (Fig. 7C). The results imply that endogenous SPAK/
OSR1 in HEK293 cells are active and inhibit the function of both
KCC2 isoforms (and possibly the function of other KCCs that are
present in HEK cells), and when DNSPAK is expressed, this inhibi-
tory effect of endogenous SPAK would be prevented, leading to
increased 86Rb uptake. Another possible explanation for the disin-
hibition of both KCC2 isoforms by DNSPAK is the SPAK-
independent effect of WNK3 on the KCC2 phosphorylation status
(e.g. via repression of protein phosphatases). In this case, the over-
expressed DNSPAK could work as a scaffold for endogenous WNK3
(via the SPAK-binding motifs present in WNKs). Consistent with
this, an increase in the transport activity of KCC2b has been
observed previously after overexpression of DNSPAK in Xenopus
oocytes (Gagnon et al., 2006b)4. Conclusions
Taken together, our data suggest a more efficient regulation of
the KCC2a than KCC2b isoform by SPAK. The different interaction
of KCC2a and KCC2b isoforms with SPAK could explain the open
question why KCC2 in adult brain is less subject to inhibitory phos-
phorylation by SPAK than that in immature brain, despite develop-
mental upregulation of SPAK (Inoue et al., 2012; Friedel et al.,
2015). We propose that the KCC2a isoform is an important compo-
nent of the intricate system regulating intracellular chloride con-
centration in neurons. Future in vivo experiments will be
required to study the phosphorylation of endogenous KCC2 iso-
forms, and to elucidate the physiological role of SPAK binding.
Whether the SPAK interaction with KCC2a is responsible for pre-
venting epitope recognition of the KCC2a-specific antibody will
also be addressed in future studies.5. Experimental procedures
5.1. Expression constructs
KCC2a and KCC2b expression constructs were described previ-
ously (Uvarov et al., 2007). HA-tagged SPAK (HA-SPAK) and domi-
nant negative, kinase-inactive K101R form of SPAK (DNSPAK)
(Dowd and Forbush, 2003) were a kind gift of Dr. B. Forbush.
5.2. Neuronal cultures
Standard dissociated hippocampal neuronal cultures were pre-
pared from embryonic day 17 (E17) mice as described previously
(Banker and Goslin, 1998) with small modifications. Briefly, hip-
pocampal cells were dissociated by enzymatic treatment (0.25%
trypsin for 15 min at 37 C) and plated (50,000 cells/cm2) on
poly-DL-ornithine-coated coverslips (Sigma, St. Louis, MO). The
cells were grown in Neurobasal medium containing B27 supple-ment (Invitrogen, Carlsbad, CA) preincubated on astroglial cultures
for 24 h. Standard dissociated cortical cultures were prepared from
embryonic day 18 (E18) rats similar to the protocol described
above for the hippocampal neuronal cultures. Neurons were plated
(100,000 cells/cm2) on poly-DL-ornithine-coated coverslips
(Sigma, St. Louis, MO) and were grown in Neurobasal medium con-
taining B27 supplement, glutamine, and penicillin + streptomycin
antibiotics mix (Neurobasal medium and all additives were from
Invitrogen/Gibco, Carlsbad, CA).
5.3. Mice and rats
All procedures related to a treatment and a care of animals were
in accordance with national and international guidelines and
approved by the National Animal Experiment Board, Finland. Mice
and rats were housed under standard conditions. Rats as well as
wild-type NMRI and C57Bl/6JHsd mice of both sexes were obtained
from a local breeding center (Experimental Animal Center, Univer-
sity of Helsinki) at different ages. KCC2b-knockout (Woo et al.,
2002) and KCC2null mice (Tornberg et al., 2005) have been charac-
terized previously.
5.4. KCC2 antibodies
The affinity-purified KCC2a antiserum was produced in rabbits
against a 21-amino acid peptide corresponding to the N-terminus
of the mouse KCC2a isoform (amino acids 20–40; DPESRRHS-
VADPRRLPREDVK) (Uvarov et al., 2009). Polyclonal antibodies
against the KCC2b isoform were generated in chicken against a
15-amino acid peptide corresponding to the N-terminus of the
mouse KCC2b isoform (amino acids 8–22; CEDGDGGANPGDGNP)
(Markkanen et al., 2014). The KCC2pan antiserum was raised in
rabbits against a recombinant 117-amino acid segment of the C-
terminus of rat KCC2 (amino acids 929–1045) common to both
KCC2a and KCC2b (Ludwig et al., 2003).
5.5. Western blot
Cultured neurons and human embryonic kidney (HEK) 293 cells
(CLR-1573, American Type Culture Collection, Manassas, VA) were
homogenized in a lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1%
Triton X-100, 0.5% deoxycholic acid, 0.1% SDS, pH 8.0) supple-
mented with the Complete Protease Inhibitor Cocktail and the
PhosStop phosphatase inhibitor cocktail (both from Roche Diag-
nostics, Mannheim, Germany). Protein concentration was deter-
mined using the DC Protein Assay kit (Bio-Rad, Hercules, CA).
Protein samples were separated using Criterion XT Precast Bis-
Tris gels (Bio-Rad Laboratories Inc, CA) and transferred onto
Hybond-ECL nitrocellulose membrane (GE Healthcare, UK). To
assess an impact of the KCC2a isoform to the total KCC2 (KCC2a
+ KCC2b) expression, we used the previously developed method
(Uvarov et al., 2009). Briefly, KCC2a protein standards (five serial
dilutions) were run on the same SDS-PAGE alongside with experi-
mental protein lysates. The KCC2a protein standards contained
epitopes for anti-KCC2a and anti-KCC2pan antibodies, thus allow-
ing quantification of KCC2a and total KCC2 (KCC2a + KCC2b)
expression using standard curves. Blots were probed with rabbit
anti-KCC2a (1:2000) (Uvarov et al., 2009), chicken anti-KCC2b
(1:2000) (Markkanen et al., 2014), rabbit anti-KCC2pan (1:2000)
(Ludwig et al., 2003), rabbit anti-SPAK (1:2000) (Ushiro et al.,
1998) (a kind gift of Dr. H. Ushiro), mouse anti-(neuronal class III
ß-tubulin) (1:10,000) (BabCO, Berkeley, CA), and mouse mono-
clonal anti-HA (12CA5) (1:2000) antibodies with subsequent prob-
ing with horseradish peroxidase conjugated goat anti-rabbit IgG
(GE Healthcare, UK), goat anti-chicken IgY (Abcam) or goat anti-
mouse IgG (DAKO, Denmark) antibodies. Blots were developed
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IL) and visualized with the luminescent image analyzer LAS-3000
(Fuji Photo Film, Tokyo, Japan). Optical densities of the bands were
analyzed with Advanced Image Data Analysis (AIDA) imaging soft-
ware (Raytest, Straubenhardt, Germany). KCC2a fraction in the
total KCC2 protein expression was determined as described previ-
ously (Uvarov et al., 2009).
5.6. Quantitative RT-PCR
Total RNA was isolated from dissociated rat cortical cultures
using RNeasy Plus Mini kit (Qiagen). Typically, 0.3 lg of total
RNA was reverse-transcribed using Maxima First Strand cDNA Syn-
thesis kit (Thermo Scientific) and a mixture of oligo(dT)18 and ran-
dom hexamer primers according to the manufacturer’s protocol.
The cDNA samples were amplified using the Maxima SYBR Green
qPCR kit (Thermo Scientific) and detected via the CFX96 Real-
Time PCR Detection System (Bio-Rad). Primers for KCC2a (50-gccg
gctcccgagggaag-30, 50-cttctccgtgtccgtgctgttgatg-30), KCC2pan (50-tc
ctcaaacagatgcacctcacca-30, 50-acgctgtctcttcgggaacattga-30), and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (50-cagtgc
cagcctcgtctcata-30, 50-tggtaaccaggcgtccgata-30) quantification were
designed with Express v2.0 software (Applied Biosystems) or man-
ually and contained at least one intron in between.
5.7. Immunocytochemistry
Hippocampal neuronal cultures were fixed for 10 min in 20 C
cold methanol, washed in phosphate-buffered saline (PBS), and
blocked for 1 h at 24 C in a blocking solution (4% BSA, 3% sheep
serum, 0.2% Triton X-100, in PBS). The cells were first incubated
in 2% BSA/1.5% sheep serum/0.2% Triton-X100 in PBS containing
anti-KCC2pan rabbit polyclonal antibody (1:1000) at 24 C for
2 h, washed three times for 10 min with PBS, and then incubated
with cyanine 3-conjugated donkey anti-rabbit secondary antibody
(1:400) (Jackson ImmunoResearch, West Grove, PA). After three
washings for 10 min in PBS and one washing in water, processed
coverslips were mounted in Gelvatol (Biomedia, Foster City, CA).
Fixation and immunostaining of cortical cultures were performed
as described for hippocampal cultures, except that normal donkey
serum was used instead of sheep serum. As primary antibodies,
anti-KCC2a rabbit (1:1000) and anti-KCC2b chicken (1:1000) poly-
clonal antibodies were used. Primary antibodies were then
detected using cyanine 3-conjugated donkey anti-rabbit (1:400)
or cyanine 3-conjugated donkey anti-chicken (1:400), respectively
(both secondary antibodies from Jackson ImmunoResearch, West
Grove, PA). Coverslips were mounted in Vectashield HardSet
Mounting Medium.
5.8. Electrophysiological recordings
Standard dissociated hippocampal neuronal cultures were pre-
pared from embryonic day 17 (E17) mice homozygous for the
KCC2null mutation (Tornberg et al., 2005) as described above. At
DIV8, cells were cotransfected by EGFP with either KCC2a or empty
expression vector. Efficiency of Cl- extrusion by KCC2 was assessed
in DIV10 EGFP-positive neurons as described previously (Khirug
et al., 2005). Briefly, we applied a constant Cl- load (19 mM) via
the somatic patch pipette and compared the reversal potential of
GABAergic currents (EGABA) after stimulation at the soma to that
after stimulation at a dendritic location, approximately 50 lm
from soma. GABA was photolysed (by UV-mediated focal photoly-
sis) from a CNB-caged GABA compound (2 mM in the extracellular
solution) (Molecular Probes, OR, USA). Diameter of the uncaging
spot is 10 mm as determined previously (Fig. 1D in Khirug et al.,
2005). The spreading of GABA to distal areas is in additionsignificantly decreased by the constant perfusion of the neurons
with fresh extracellular solution. Under such conditions, difference
between EGABA values measured after GABA-uncaging at the soma
and at the dendrite (the somato-dendritic EGABA gradient) can be
attributed to Cl- extrusion by KCC2. Recordings were performed
in the extracellular solution (127 mM NaCl, 3 mM KCl, 2 mM CaCl2,
1.3 mM MgCl2, 10 mM D-glucose, and 20 mM HEPES, pH 7.4. at
room temperature in the whole-cell voltage-clamp configuration.
NKCC1 was blocked throughout the experiments with 10 lM
bumetanide, action potentials with 1 lM TTX and GABAB receptors
with 1 lM CGP 55845 (Tocris, Bristol, UK). Borosilicate glass
(Harward Apparatus, UK) patch pipettes with resistances ranged
from 6.5 to 7.5 MX were filled with intracellular solution
(18 mM KCl, 111 mM K-gluconate, 0.5 mM CaCl2, 2 mM NaOH,
10 mM D-glucose, 10 mM HEPES, and 2 mM Mg-ATP, 5 mM BAPTA,
pH 7.3). Recordings from EGFP-positive neurons with access resis-
tances between 10 and 20 MX were used for analysis. All mem-
brane potential values were corrected for a liquid-junction
potential of 10 mV. EGABA was derived from the current–voltage
(I–V) plot obtained by sequentially clamping the somatic mem-
brane at different voltage levels. I–V curves were normalized with
respect to peak IGABA at the most negative holding potential (Vh)
tested. After the experiments, neuronal cultures were fixed in 4%
paraformaldehyde (PFA) and immunostained with rabbit anti-
KCC2pan antibodies to demonstrate the level of KCC2 expression
in the neurons transfected with the KCC2a expression construct
versus non-transfected neurons.
5.9. Calcium imaging
Dissociated rat cortical cultures were prepared from E18
embryos and plated (100,000 cells/cm2) on 35 mm MatTek dishes
(MatTek Corporation, MA, USA) with 10 mm glass microwell bot-
tom pre-coated with poly-L-lysine as described above. Cultures
were cotransfected at DIV3 with a mix containing EGFP and one
of the expression constructs (KCC2a, KCC2b, or empty vector as a
control), and Ca2+ imaging was performed at DIV6 as described
previously (Sokka et al., 2007) with small modifications. Conven-
tional wide-field fluorescence microscopy integrated in CellR
Olympus IX71 microscope system equipped with a 10x objective
and CCD camera (Orca, Hamamatsu, Japan) was used to monitor
the muscimol-induced Ca2+ responses. Cells were loaded with
5 lM calcium indicator Fura-2 acetoxymethyl ester (AM) (Invitro-
gen) supplied with 0.02% Pluronic F-127 (Sigma–Aldrich) by incu-
bation at room temperature for 30 min in the extracellular solution
(127 mM NaCl, 3 mM KCl, 2 mM CaCl2, 1.3 mM MgCl2, 20 mM
HEPES, and 10 mM glucose, pH 7.4). After washing out Fura-2
AM cells were incubated during 20 min for de-esterification, dur-
ing which the EGFP-positive neurons were identified for subse-
quent Ca2+ recordings. To analyze Ca2+ transient responses in the
EGFP-positive as well as in the nearby untransfected cells, intensi-
ties of the fluorescent signals collected using a 410 nm dichroic
mirror and a 505 nm barrier filter after consecutive excitation of
the measured cells at 340 and 380 nm were recorded
(Grynkiewicz et al., 1985). Changes in [Ca2+]i were expressed as
DF/F, where F is baseline fluorescence level, DF is the relative
change from the base level of the 380 nm component. Due to a rel-
atively low intensity of the 340 nm component for the particular
combination of the filters and objective in our experiments, only
the 380 nm component was taken for subsequent analysis. A stan-
dard protocol included 1 min basal recording, after which musci-
mol (50 mM) was applied during 1 min through a bath perfusion
system. To discriminate between glial cells and neurons, we used
a previously described protocol that takes into account their differ-
ent Ca2+ responses on application of low external [K+] (Dallwig and
Deitmer, 2002). Viability of the recorded cells was assessed in high
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CaCl2, 1.3 mM MgCl2, 20 mM HEPES, and 10 mM glucose, pH 7.4).
Only those neurons that responded with Ca2+ increase on applica-
tion of 50 mM KCl but not on low [K+] were used in the subsequent
analysis.5.10. Biotinylation assay
Rat cortical cultures (100,000 cells/cm2) were grown under
standard conditions in 6-well plates as described above. DIV12 cul-
tures were used for biotinylation assays. Pierce Cell Surface Protein
Isolation Kit was used according to manufacturer’s instructions
with some modifications. In brief, cultures were placed on ice,
rinsed twice in ice-cold PBS-Ca-Mg (PBS + 0.1 mM CaCl2 + 1 mM
MgCl2) and then pre-incubated in 1.5 ml of cold PBS-Ca-Mg for
30 min at 4 C. Cells were incubated in 1.5 ml of freshly prepared
0.25 mg/ml Sulfo-NHC-LC-Biotin diluted in cold PBS-Ca-Mg for
30 min at 4 C. Cells were rinsed twice in cold PBS-Ca-Mg, and then
a cold quenching solution containing 0.1 M glycine in PBS-Ca-Mg
was added for 20 min. Cells were rinsed twice in cold PBS-Ca-Mg
and collected by scraping into 250 ml per well of lysis buffer con-
taining protease inhibitors. Cell lysates were incubated for
15 min on ice, mixed, centrifuged at 10,000g for 10 min at 4 C,
and supernatant was collected. Ten percent of the collected lysate
was taken and stored for subsequent immunoblotting as a total
protein sample. NeutrAvidin Agarose slurry (100 ml) was loaded
into Pierce columns and washed according to instructions. The
clarified cell lysate (the remaining 90%) was added to the agarose
slurry and incubated overnight at +4 C with rotation. The next
day the column was centrifuged and the agarose beads were
washed two times with 500 ml of TNE buffer (1% Nonidet P-40,
50 mM Tris-HCl, pH 8.0, 140 mM NaCl, 5 mM EDTA) supplemented
with the Complete Protease Inhibitor Cocktail and the PhosStop
phosphatase inhibitor cocktail (both from Roche Diagnostics, Man-
nheim, Germany), and then three times with 100 ml of the Wash
buffer (Pierce) with protease inhibitors. Proteins were eluted in
100 ml of the SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8,
1% SDS, 10% glycerol) containing 50 mM DTT. Samples were incu-
bated for 60 min at room temperature with rotation, centrifuged
for 2 min, and the eluate was collected. A trace amount of bro-
mophenol blue was added and the samples were analyzed by
immunoblotting as described above.5.11. Immunohistochemistry
Adult C57Bl/6JHsd (Harlan, Blackthorn Bicester, UK) mice of
both sexes were used for immunohistochemistry. Mice were dee-
ply anesthetized by pentobarbital and perfused with 4% PFA in
PBS. Brains were collected and postfixed in PFA for 2 h, cryopro-
tected in 30% sucrose overnight, and frozen in TissueTek (O.C.T
compound, Sakura). Free-floating cryosections (40 lm) were used
immediately for immunostaining or stored at 20 C in a cryopro-
tective medium. Immunostainings were performed as described
previously (Markkanen et al., 2014). To reduce the nonspecific sig-
nal, the KCC2a antiserumwas preabsorbed against PFA-fixed tissue
from KCC2a-KO mice, as described previously (Markkanen et al.,
2014). P7 wild-type and KCC2b-deficient mice (Woo et al., 2002)
were perfused with 4% PFA in PBS, brains were collected and post-
fixed with the same fixative for 2 h. Brains were soaked in 30%
sucrose in PBS for at least 24 h, and frozen in TissueTek. Coronal
cryosections (20 mm) were cut and placed on Superfrost Plus slides
(Menzel-Gläser, Braunschweig, Germany), and stored at 20 C
until use. Sections were rinsed in PBS 3 times for 10 min and
blocked with 5% normal donkey serum and 0.3% Triton X-100 in
PBS for 30 min at room temperature. Sections were incubated withdilutions of primary antibody: rabbit anti-KCC2a antibody (1:750)
or rabbit anti-KCC2pan antibody (1:1000) in a blocking buffer
overnight at 4 C. Sections were washed with PBS, incubated with
donkey anti-rabbit IgG-Cy3 (1:150, Jackson) in a blocking buffer for
2 h, washed with PBS, and finally mounted on slides with PBS-
glycerol.5.12. Coimmunoprecipitation (coIP) assay
CoIP experiments were performed according to (Cai et al., 2002)
with small modifications. Human embryonic kidney (HEK) 293
cells (CLR-1573, American Type Culture Collection, Manassas, VA)
were cultured (in 10 cm plates) in DMEM supplemented with
10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, and 2 mM L-glutamine. Cells were transfected with appro-
priate expression constructs using jetPEI cationic polymer
transfection reagent (Polyplus-transfection Inc., NY) according to
the manufacturer’s protocol. Transfected HEK293 cells were rinsed
twice with ice-cold PBS, lysed for 15 min in ice-cold TNE buffer
(140 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 50 mM Tris-HCl pH
8.0), supplemented with the Complete Protease Inhibitor Cocktail
and the PhosStop phosphatase inhibitor cocktail (both from Roche
Diagnostics, Mannheim, Germany), and centrifuged for 10 min at
+4 C to remove particulate matter. Supernatant was precleared
for 1 h at +4 C using blocked GammaBind G Sepharose (GE Health-
care, Uppsala, Sweden) and further incubated overnight with 2 lg
of the appropriate antibody. Thereafter, the blocked protein-G
Sepharose was added and incubation was continued for 2 h. After
washing of the Sepharose beads twice with the ice-cold TNE buffer
for 10 min and twice with PBS for 5 min, the bound proteins were
eluted by SDS sample buffer (1% SDS, 100 mM DTT, 50 mM Tris, pH
7.5) and separated by SDS-PAGE.5.13. Functional 86Rb flux assay
Flux experiments were performed in HEK293 cells at room tem-
perature as described previously (Uvarov et al., 2007) with small
modifications. One day before the measurements, the cells were
transfected with the indicated expression constructs using jetPEI
cationic polymer transfection reagent (Polyplus-transfection Inc.,
NY, USA) according to the manufacturer’s protocol. On the day of
the flux experiments, the cells were washed three times in control
medium (135 mM NaCl, 5 mM RbCl, 1 mM MgCl2, 1 mM CaCl2,
1 mM Na2HPO4, 2 mM Na2SO4, 3 mM glucose, 15 mM HEPES, pH
7.4, 0.1 mM ouabain, and 10 lM bumetanide) complemented
when required with 2 mM furosemide. The cells were then incu-
bated for 3 min in the control medium containing 2 lCi/ml 86RbCl
(PerkinElmer, MA). 86Rb influx was terminated by five washings in
ice-cold control medium containing 2 mM furosemide. Cells were
dried and intensity of 86Rb signal was analyzed using PhosphoI-
mager (Fuji) by pre-exposing the culture plates with the phospho-
rimaging BAS-MP 2040S screen from Fuji (Tokyo, Japan).5.14. Statistical analysis
GraphPad Prism 5 (GraphPad Software, Inc, CA) was used to
perform all statistical analysis including confirmation of similar
variance between all groups compared and the Kolmogorov-
Smirnov test for data normality. Significance was determined by
the one-sample t-test when samples were compared to normalized
control, by two-tailed unpaired Student’s t-test when two groups
were compared, or by one-way ANOVA with Bonferroni multiple
comparisons test when more than two groups were compared. P-
values less than 0.05 were considered significant.
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